The vulnerable blood

Area of Science:

• Cardiovascular Science
• Hematology
• Metabolic Disease Research

Background:

• Diabetes mellitus significantly increases cardiovascular morbidity and mortality.
• While arteriosclerotic lesions are known contributors, blood alterations are increasingly recognized as critical factors.
• Platelet activation and fibrin clot formation are key events following plaque rupture.

Purpose of the Study:

• To review the changes in platelet function and blood clot structure in patients with diabetes.
• To explore the underlying mechanisms, including metabolic and inflammatory alterations.
• To investigate the emerging role of the complement cascade in diabetes-associated thrombosis.

Main Methods:

• Literature review of studies on diabetes, thrombosis, platelet function, and coagulation.
• Analysis of research linking metabolic and inflammatory pathways to hemostatic changes.
• Examination of evidence implicating complement system components.

Main Results:

• Diabetic patients exhibit a prothrombotic state characterized by hyper-reactive platelets.
• A tighter, more rigid clot structure results from up-regulated coagulation factors and prolonged clot lysis.
• Metabolic and inflammatory processes are key drivers, with the complement cascade emerging as a significant influence.

Conclusions:

• Diabetes profoundly alters platelet function and blood clot structure, contributing to increased thrombotic risk.
• Understanding these hematological changes is crucial for managing cardiovascular complications in diabetes.
• The complement system represents a novel therapeutic target for mitigating diabetes-related cardiovascular events.